We lack details on the situations surrounding those who passed. Plenty of people using GLP medications carry various other health issues tied to carrying extra weight. It makes sense to stay alert on this. From what I recall the most recent numbers put UK users of these drugs between 1.6 and 2 million.
A podcast covered a UK case of a 19-year-old who passed away while using tirzepatide. She had a pre-existing heart issue that might have been influenced by the medication's effects on heart rate. Across the board there are more than 200 deaths where GLP-1s showed up as involved, which simply means the individuals were also taking one at the time, with no established cause-and-effect. The close monitoring in the UK is positive, yet nothing here raises immediate red flags for me.